Drug Information

Drug General Information
Drug ID
D0Q4CX
Former ID
DIB000725
Drug Name
MLN-3126
Synonyms
CCR9 antagonist (oral, Crohn's disease), Millennium
Indication Sjogren's syndrome [ICD9: 710.2; ICD10:M35.0] Phase 1 [524863]
Company
Millennium Pharmaceuticals Inc
Target and Pathway
Target(s) CCR9 chemokine receptor Target Info Antagonist [530993], [532026]
KEGG Pathway Cytokine-cytokine receptor interaction
Chemokine signaling pathway
Intestinal immune network for IgA production
PANTHER Pathway Inflammation mediated by chemokine and cytokine signaling pathway
Reactome Chemokine receptors bind chemokines
G alpha (i) signalling events
WikiPathways GPCRs, Class A Rhodopsin-like
Peptide GPCRs
GPCR ligand binding
GPCR downstream signaling
References
Ref 524863ClinicalTrials.gov (NCT02209506) Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MLN3126 in Healthy Japanese and Non-Japanese Participants. U.S. National Institutes of Health.
Ref 530993GSK-1605786, a selective small-molecule antagonist of the CCR9 chemokine receptor for the treatment of Crohn's disease. IDrugs. 2010 Jul;13(7):472-81.
Ref 532026Targeting T-cell migration in inflammatory bowel disease. J Intern Med. 2012 Nov;272(5):411-29.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.